梅州坐打胎多少钱梅州霉菌性阴道炎要怎么治疗,梅州除掉下眼袋,梅州缩小鼻翼鼻头,梅州面部自体脂肪填,梅州做超导人流的时间,梅州人流一般价钱,梅州宫颈糜烂 leep 价格

BEIJING, May 14 (Xinhua) -- The uranium subsidiary of China Guangdong Nuclear Power Group (CGNPG) has said it is developing two large mines in the mainland.The two mines will be located in south China's Guangdong province and northwest China's Xinjiang Uygur Autonomous Region, according to Saturday's China Daily.The move is likely to add as much as 1,000 tonnes to the country's annual production capacity of the nuclear fuel."The two mines are expected to start operation in 2013, each with an annual production capacity of no more than 500 tonnes," the newspaper quoted Zhou Zhenxing, chairman of CGNPG Uranium Resources Co (CGNPG-URC) as saying.

BEIJING, March 15 (Xinhuanet) -- Chris Poole, the 22-year-old founder of 4Chan.org, criticized Facebook's approach and spoke up for online anonymity at South by Southwest Interactive in Austin, Texas, according to media reports Tuesday.Poole called out early in his keynote speech at the huge Austin tech event, referencing this Zuckerberg quote from David Kirkpatrick’s book "The Facebook Effect": "Having two identities for yourself is an example of a lack of integrity.""Anonymity is authenticity; it allows you to share in a completely unfiltered way," Poole countered. "It allows you to play in ways, you might not if people knew who you are.”Losing the ability to be anonymous on the Internet is, "a kind of loss of the innocence of youth," Poole said, crediting 4chan’s culture-infiltrating creativity to anonymity. "You can’t make mistakes,“ and then leave them behind, like the olds did pre-Facebook. If your mistakes ever made it to the Internet, they’re with you wherever you go.Poole — known by the 4chan handle "moot" — was to promote his new meme-generating venture, Canvas, still in beta testing.Launched for anime enthusiasts in 2003, 4chan is one of the most popular image-sharing bulletin boards on the Internet, with most of that traffic hitting 4chan’s notorious "random" image board, the /b/ board.

WELLINGTON, May 24 (Xinhua) -- New Zealand researchers have found a way to stop the growth of certain cancer tumors by " silencing" a group of PAX genes, members of a small family of genes that play important roles in embryonic development, but also allow cancer cells to grow and divide in adult tissue.In an article published in UK medical journal Oncogene, Otago University Professor Michael Eccles and colleagues revealed how they used the PAX8 gene to kill cancer cells.After detecting high levels of PAX8 protein in the majority of kidney, ovarian and thyroid cancers they studied, the researchers used molecular techniques to silence the PAX8 gene in several cancer cell lines."We found that these PAX8-depleted cancer cells ceased growing and dividing. The cells were essentially stopped in their tracks through the failure of multiple mechanisms and pathways crucial to their cell division cycle. They then entered into a state called senescence in which they no longer divided, and after that they ultimately died," Eccles said in a statement from the university Tuesday.The findings suggested that PAX8 could be a good target for the development of new cancer therapies, he said."Any resulting drugs would be a long way down the road, but in the meantime this research helps confirm that a focus on PAX genes may prove to be a fruitful line of attack against a number of cancers," he said.The research was supported by grants from the Health Research Council of New Zealand. It formed the main piece of work carried out by Otago doctoral graduate Caiyun (Grace) Li, now a postdoctoral fellow at Stanford University. Study co-authors also included Professor Antony Braithwaite and master's student Jen Nyman.In 2003, research led by Eccles discovered that proteins from one or more of the nine PAX genes were present in many common cancers. They found that "silencing" the gene expression of PAX2 in ovarian and bladder cancer cells, and of PAX3 in melanoma, led to the rapid death of the cells.

BEIJING, April 12 (Xinhuanet) -- Doctors may choose riskier treatment with fewer severe side effects for themselves than they'd recommend for their patients, according to a study in the Archives of Internal Medicine Tuesday. In the study, two sets of questions were sent to primary care physicians around the United States. One involved choosing between two types of colon cancer surgery and the other situation involved choosing no treatment for the flu, or choosing a made-up treatment less deadly than the disease but which could cause permanent paralysis. Of 242 physicians who answered the colon cancer questionnaire, 38 percent went with the treatment that carried a higher risk of death but fewer side effects for themselves. By contrast, only a quarter said they would recommend that treatment to their patients.In the flu scenario, 63 percent chose the deadlier option of no treatment for themselves, versus 49 percent recommending it for patients.The findings are important because patients faced with difficult medical decisions often ask their doctors, "What would you do?" The answer reflects the doctors' values -- not necessarily those of the patients.Doctors should know what their patients value most before giving advice, and patients should ask doctors the reasons behind their answers, said study author Dr. Peter Ubel, an internist and behavioral scientist at Duke University.

SAN FRANCISCO, May 25 (Xinhua) -- Micro-blogging service Twitter on Wednesday confirmed that it has bought TweetDeck, a London-based startup that develops application to help people organize information posted on Twitter."Today, we're pleased to announce that the TweetDeck team has joined Twitter," Dick Costolo, Twitter's chief executive officer (CEO), said in a blog post."This acquisition is an important step forward for us. TweetDeck provides brands, publishers, marketers and others with a powerful platform to track all the real-time conversations they care about," he added.Founded in 2008, TweetDeck now has a team of 15 and offers a real-time application that allows users to monitor abundance of information from social media services including Twitter in a single concise view."Change may well be inevitable, but we remain the same team, staying in London, with the same focus and products, and now with the support and resources to allow us to grow and take on even bigger challenges," Iain Dodsworth, founder and CEO of TweetDeck, noted in a separate blog post.The deal is a defensive move for Twitter aimed at preventing TweetDeck from being purchased by rivals, some analysts said.Financial terms of the transaction were not disclosed, but technology blog site TechCrunch and other U.S. media reported that Twitter paid 40 million to 50 million U.S. dollars.